Related Experiment Video
Updated: Aug 14, 2026
07:27
The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury
Published on: October 21, 2017
Pathophysiological basis for antioxidant therapy in chronic liver disease
Jesús Medina1, Ricardo Moreno-Otero
1Unidad de Hepatología, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Spain.
Drugs
|November 22, 2005
Summary
Antioxidants may treat liver damage caused by oxidative stress. Pilot trials show promise for antioxidants like vitamin E, suggesting further research in chronic liver disease is warranted.
Area of Science:
- Hepatology and Molecular Medicine
- Oxidative Stress and Antioxidant Research
Background:
- Oxidative stress, an imbalance between reactive oxygen/nitrogen species and antioxidants, is a key factor in liver damage across various liver disorders.
- Cellular damage in the liver arises from an excess of oxidants or a deficiency in antioxidant defenses.
Purpose of the Study:
- To explore the therapeutic potential of antioxidants in managing chronic liver disease.
- To review the current evidence supporting antioxidant strategies for liver pathologies.
Main Methods:
- Review of experimental research on cellular mechanisms regulating oxidant-antioxidant balance.
- Analysis of pilot clinical trial data for antioxidant efficacy in liver diseases.
- Consideration of combining antioxidants with anti-inflammatory or antiviral therapies.
Main Results:
- Experimental research has advanced understanding of cellular redox regulation.
- Pilot trials suggest promising results for antioxidants such as S-adenosylmethionine (SAMe), vitamin E (tocopherol), polyenylphosphatidylcholine, and silymarin in specific liver conditions.
- Evidence supports the rationale for antioxidants as a logical therapeutic approach for chronic liver disease.
Conclusions:
- Antioxidants represent a promising therapeutic strategy for chronic liver diseases.
- Further multicenter clinical studies are recommended, potentially combining antioxidants with other therapies.
- Oxidative stress is implicated in alcoholic liver disease, viral hepatitis, autoimmune liver diseases, and non-alcoholic steatohepatitis.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:24Liver Regeneration
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...